TAMARA PINTO: Open Payments
NPI 1316270523 · BRISTOL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 101 payments from 19 companies in 2025. Trend: 2023 $1,975 · 2024 $1,903 · 2025 $1,975
Food & beverage: $1,975
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $300 |
| Lilly USA, LLC | 9 | $257 |
| AstraZeneca Pharmaceuticals LP | 12 | $223 |
| Amgen Inc. | 9 | $210 |
| ABBVIE INC. | 9 | $179 |
| GlaxoSmithKline, LLC. | 12 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Novo Nordisk Inc | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Exact Sciences Corporation | 4 | $67 |
Products named: MOUNJARO, OTEZLA, TRELEGY ELLIPTA, VRAYLAR, NURTEC ODT, JARDIANCE, FARXIGA, ZAVZPRET.
Industry payments across IN — which companies pay providers there.
